Superworth

Kymera Therapeutics market cap KYMR

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 2, 2026
$10.6B
Highest close in our data
$10.6B
Nov 2026

Kymera Therapeutics is worth $10.6B at the close on Nov 2, 2026, at $127.51 a share.

That is up 151% over the last year and up 220% over five years.

Its highest close in our data was $10.6B in Nov 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$10.6B$5B$10.6B+81%
2025$5.9B$1.4B$6.5B+125%
2024$2.6B$1.5B$3.3B+84%
2023$1.4B$607.9M$2B+3%
2022$1.4B$765M$2.9B−58%
2021$3.3B$1.5B$3.5B+18%
2020$2.8B$2B$3.8Bn/a

Against its peers

Companies in Biotechnology nearest Kymera Therapeutics' size, closest first, today.

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Kymera Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.